Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical UniversityActive in the last 2 years

Yangyang Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2964-2803; OpenAlex author ID A5055451466. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Evaluation of the efficacy and predictive indicators of PD- 1 inhibitors combined with chemotherapy in advanced pancreatic cancer. First author DOI 10.1038/s41598-025-97233-7↗
  2. Integrated transcriptomic analysis reveals hub genes involved in diagnosis and prognosis of pancreatic cancer. Co-author DOI 10.1186/s10020-019-0113-2↗
  3. Sp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.8593↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tiantian Zhang · 1 shared paper, 2025 · strength 0.30
  2. Rui Wang · 1 shared paper, 2025 · strength 0.30
  3. Xiaojing Du · 1 shared paper, 2019 · strength 0.10
  4. Meng Zhuo · 1 shared paper, 2016 · strength 0.06
  5. Ting Han · 1 shared paper, 2016 · strength 0.06
  6. Feng Jiao · 1 shared paper, 2016 · strength 0.06
  7. Hai Xia Hu · 1 shared paper, 2016 · strength 0.06
  8. Junjie Huang · 1 shared paper, 2016 · strength 0.06
  9. Junjie Hang · 1 shared paper, 2016 · strength 0.06
  10. Liwei Wang · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.